Implantable systems, and method for use therewith, are provided that take
advantage of various neuromodulation and neurosensing techniques for
either preventing atrial fibrillation (AF) or terminating AF. Specific
embodiments, as will be described below, are for use with an implantable
device that include one or more atrial electrode for sensing atrial
fibrillation (AF) and/or delivering AATP and one or more electrode for
monitoring and/or stimulating atrial vagal fat pads.